Min Xu

机构：Shanghai Tenth People's Hospital · ORCID：0000-0001-9091-6757

发表论文 83 篇 · 总被引 1424 次 · h-index 17

代表论文

• LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation (2025 · Cancer Letters · 被引 13)
• Tumor-associated neutrophils: a complex role in cancer (2025 · Clinical Immunology · 被引 4)
• Liver ischemia-reperfusion promotes tumor metastasis via neutrophil-endothelial interactions: targeting ICAM1 to prevent metastatic recurrence (2025 · Journal of Translational Medicine · 被引 1)
• DysUFMylation of SREBP1 Promotes the Progression of Hepatocellular Carcinoma by Reprogramming Lipid Metabolism (2025 · Journal of Clinical and Translational Hepatology · 被引 1)
• Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis (2025 · 被引 1)
• Figure S9 from UFMylation Suppresses Hepatocellular Carcinoma Metastasis by Inhibiting β-Catenin–Driven Hybrid EMT and NK Cell Evasion (2026)